Philips’ Direct-to-angio Stroke Pathway: New Analysis Demonstrates Substantial Cost Savings in Addition to Improved Patient Outcomes
Amsterdam, the Netherlands, June 14 (Korea Bizwire) – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the results of a health economic analysis published in the Journal of NeuroInterventional Surgery (JNIS) that show an innovative approach to the stroke care pathway reduced costs by an average of EUR 2,848 (~USD 3,120) per patient. [...]










